These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 32431515)
1. Long Non-Coding RNA NNT-AS1 Contributes to Cisplatin Resistance via miR-1236-3p/ATG7 Axis in Lung Cancer Cells. Wang H; Guo M; Ding D; Yang F; Chen Z Onco Targets Ther; 2020; 13():3641-3652. PubMed ID: 32431515 [TBL] [Abstract][Full Text] [Related]
2. LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis. Liu Y; Guo R; Qiao Y; Han L; Liu M Cancer Cell Int; 2020; 20():190. PubMed ID: 32489326 [TBL] [Abstract][Full Text] [Related]
3. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway. Cai Y; Dong ZY; Wang JY Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4879-4887. PubMed ID: 30070323 [TBL] [Abstract][Full Text] [Related]
4. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis. He W; Zhang Y; Xia S Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA OIP5-AS1 contributes to cisplatin resistance of oral squamous cell carcinoma through the miR-27b-3p/TRIM14 axis. Xiao Z; Li J; Jin Q; Liu D Exp Ther Med; 2021 Apr; 21(4):408. PubMed ID: 33692839 [TBL] [Abstract][Full Text] [Related]
6. LncRNA NNT-AS1 regulates the progression of lung cancer through the NNT-AS1/miR-3666/E2F2 axis. Huang JW; Luo XY; Li ZH; Lang BP Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):238-248. PubMed ID: 31957837 [TBL] [Abstract][Full Text] [Related]
7. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p. Wang D; Zheng Y Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561 [TBL] [Abstract][Full Text] [Related]
8. Long Non-Coding RNA TP73-AS1 Promotes the Development of Lung Cancer by Targeting the miR-27b-3p/LAPTM4B Axis. Jiang Q; Xing W; Cheng J; Yu Y Onco Targets Ther; 2020; 13():7019-7031. PubMed ID: 32764992 [TBL] [Abstract][Full Text] [Related]
9. OIP5-AS1 promotes the progression of gastric cancer cells via the miR-153-3p/ZBTB2 axis. Zhi XH; Jiang K; Ma YY; Zhou LQ Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2428-2441. PubMed ID: 32196594 [TBL] [Abstract][Full Text] [Related]
10. LncRNA FOXD3-AS1 promoted chemo-resistance of NSCLC cells via directly acting on miR-127-3p/MDM2 axis. Zeng Z; Zhao G; Zhu H; Nie L; He L; Liu J; Li R; Xiao S; Hua G Cancer Cell Int; 2020; 20():350. PubMed ID: 32742197 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA FGD5-AS1 contributes to cisplatin resistance in hepatocellular carcinoma via sponging microRNA-153-3p by upregulating Twinfilin Actin Binding Protein 1 (TWF1). Yang Y; Shi L; Zhang D; Wu D; An Y; Zhang Y; Chen X Bioengineered; 2021 Dec; 12(1):6713-6723. PubMed ID: 34519634 [TBL] [Abstract][Full Text] [Related]
12. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis. Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833 [TBL] [Abstract][Full Text] [Related]
13. Knockdown of lncRNA ACTA2-AS1 reverses cisplatin resistance of ovarian cancer cells via inhibition of miR-378a-3p-regulated Wnt5a. Lin C; Zheng M; Yang Y; Chen Y; Zhang X; Zhu L; Zhang H Bioengineered; 2022 Apr; 13(4):9829-9838. PubMed ID: 35412951 [TBL] [Abstract][Full Text] [Related]
14. Circular RNA PRMT5 confers cisplatin-resistance via miR-4458/REV3L axis in non-small-cell lung cancer. Pang J; Ye L; Zhao D; Zhao D; Chen Q Cell Biol Int; 2020 Dec; 44(12):2416-2426. PubMed ID: 32808744 [TBL] [Abstract][Full Text] [Related]
15. The knockdown of LncRNA AFAP1-AS1 suppressed cell proliferation, migration, and invasion, and promoted apoptosis by regulating miR-545-3p/hepatoma-derived growth factor axis in lung cancer. Sun J; Min H; Yu L; Yu G; Shi Y; Sun J Anticancer Drugs; 2021 Jan; 32(1):11-21. PubMed ID: 33290312 [TBL] [Abstract][Full Text] [Related]
16. Identification of circ_0058357 as a regulator in non-small cell lung cancer cells resistant to cisplatin by miR-361-3p/ABCC1 axis. Chu D; Li P; Li Y; Shi J; Huang S; Jiao P Thorac Cancer; 2021 Nov; 12(21):2894-2906. PubMed ID: 34523261 [TBL] [Abstract][Full Text] [Related]
17. MiR-874-3p represses the migration and invasion yet promotes the apoptosis and cisplatin sensitivity via being sponged by long intergenic non-coding RNA 00922 (LINC00922) and targeting Glycerophosphodiester Phosphodiesterase Domain Containing 5 (GDPD5) in gastric cancer cells. Zhang X; Dai X; Zhao X; Wang J; Dou J; Zhuang H; Chen N; Zhao H Bioengineered; 2022 Mar; 13(3):7082-7104. PubMed ID: 35282764 [TBL] [Abstract][Full Text] [Related]
18. Knockdown of cir_RNA PVT1 Elevates Gastric Cancer Cisplatin Sensitivity via Sponging miR-152-3p. Wang X; Zhang Y; Li W; Liu X J Surg Res; 2021 May; 261():185-195. PubMed ID: 33444948 [TBL] [Abstract][Full Text] [Related]
19. CircRNA_100565 contributes to cisplatin resistance of NSCLC cells by regulating proliferation, apoptosis and autophagy via miR-337-3p/ADAM28 axis. Zhong Y; Lin H; Li Q; Liu C; Shen J Cancer Biomark; 2021; 30(2):261-273. PubMed ID: 33682697 [TBL] [Abstract][Full Text] [Related]
20. LncRNA NNT-AS1 promotes lung squamous cell carcinoma progression by regulating the miR-22/FOXM1 axis. Ma J; Qi G; Li L Cell Mol Biol Lett; 2020; 25():34. PubMed ID: 32514270 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]